SEC Filing Summary for Angiodynamics Inc. - Form 4 Filing

This filing details transactions by Nighan Warren JR, SVP Quality and Regulatory at Angiodynamics Inc. On July 16, 2026, 2,153 shares of common stock were disposed of with a price per share of $14.14, leaving 67,750 shares. This disposition was to satisfy tax withholding obligations related to the vesting of restricted stock units. On July 17, 2026, 1,373 shares were disposed of at $13.51 per share, reducing the post-transaction holdings to 66,377 shares, also for tax withholding purposes. A further disposition of 251 shares occurred on July 20, 2026, at $13.71 per share, resulting in 66,126 shares remaining, again to cover tax withholding obligations from vested restricted stock units. All transactions were direct holdings and deemed exempt.